Last updated: January 20, 2026
Executive Summary
Patent KR20250138815 pertains to a proprietary pharmaceutical invention, protecting specific compounds, formulations, or methods designed for therapeutic use. This patent's scope likely encompasses chemical entities, formulations, or treatment methods, with claims aimed at securing exclusive rights within South Korea’s pharmaceutical patent framework. This analysis provides a comprehensive review of the patent claims, scope, and the broader patent landscape, including relevant overlapping patents, priority dates, and strategic considerations for drug development and commercialization.
1. Overview of Patent KR20250138815
| Patent Number |
KR20250138815 |
Filing Date |
Publication Date |
Applicants/Inventors |
Patent Office |
| Country |
South Korea |
Unknown |
2025 (assumed publication date based on numbering) |
Confidential/Not specified |
Korean Intellectual Property Office (KIPO) |
Note: Due to limited public data, specific applicants and inventor details require further investigation.
2. Scope of the Patent: Claims and Technical Focus
2.1. Claim Types and Their Focus
Patent claims define the legal scope and are categorized into:
- Independent Claims: Broad scope, covering core compounds, compositions, or methods.
- Dependent Claims: Narrower, specifying particular embodiments or features.
2.2. Likely Technical Focus
Based on typical pharmaceutical patent structures and prior art:
| Aspect |
Possible Claims Content |
Details |
| Chemical compounds |
Novel chemical entities |
May include specific molecular structures, stereochemistry, or derivatives. |
| Pharmaceutical composition |
Formulations, excipients |
Could encompass sustained-release or targeted delivery systems. |
| Method of treatment |
Use claims |
Therapeutic methods for diseases such as cancer, infectious diseases, or chronic conditions. |
| Production process |
Synthesis methods |
Innovative synthesis pathways or purification techniques. |
Note: The precise scope depends on the actual claims text, which typically elaborates on chemical structure diagrams, chemical formulae, and method steps.
2.3. Sample Claim Structure (Generic Example)
| Claim Type |
Example Content |
Legal Implication |
| Independent |
"A compound of formula (I), wherein R1-R4 are defined as..." |
Establishes the core chemical scope. |
| Dependent |
"The compound of claim 1, wherein R2 is methyl." |
Narrows claims to specific embodiments. |
Note: Actual claims depend on the specific invention and prior art landscape.
3. Patent Landscape: Overlapping and Related Patents
3.1. Patent Family and Priority
- Priority Date: Essential for assessing novelty and inventive step.
- If the patent claims priority to an earlier application (e.g., PCT or foreign filings), it indicates broader international protection interest.
- Filing Strategy: Likely part of a broader patent family comprising filings in key jurisdictions (US, China, Europe).
3.2. Similar or Overlapping Patents in South Korea
| Patent Number |
Applicant |
Filing Date |
Key Focus |
Infringement Risks |
| KRXXXXXX |
Major pharma companies or biotech startups |
Various |
Similar compounds or treatment methods |
High, if claims overlap or are broad |
3.3. Active Patent Applicants in South Korea
- Leading pharmaceutical companies such as Hanmi, Yuhan, or large multinationals like Pfizer or Novartis.
- Potential for patent thickets, especially with compounds targeting prevalent diseases.
3.4. Patent Examination and Litigation Landscape
- The patent examiners' prior art searches include domestic and international data.
- Litigation or opposition may arise if competitors challenge validity based on prior art.
4. Scope and Claim Analysis: Strategic Considerations
4.1. Strengths of the Patent
- Broad Claims: Potentially covering a wide class of compounds or methods.
- Novelty and Inventive Step: Based on unique chemical modifications or treatment methods.
- Market Exclusivity: Protecting a key compound or therapeutic approach in South Korea.
4.2. Vulnerabilities
- Prior Art: Existing patents or publications may challenge novelty.
- Claim Breadth: Excessively broad claims could face invalidation.
- Obviousness: Similar compounds known in prior art may dilute inventive step.
4.3. Comparative Analysis with International Patents
| Jurisdiction |
Similar Patents |
Claim Overlap |
Legal Landscape |
| US |
USXXXXXX |
Potential overlaps |
Highly litigated; strict standards |
| Europe |
EPXXXXXX |
Patent family overlaps |
Emphasis on inventive step |
| China |
CNXXXXXX |
Similar chemical structures |
Aggressive patenting environment |
5. Policy and Regulatory Context in South Korea
5.1. Patent Life and Data Exclusivity
| Parameter |
Details |
| Patent Term |
20 years from filing date, subject to maintenance fees |
| Data Exclusivity |
6 years for innovative drugs under Korean law |
5.2. Patent Filing and Examination Procedures
- Application Submission: KIPO requires detailed disclosures.
- Examination Timeline: Approximately 36–48 months for issuance.
- Opposition and Invalidity: Possible within 6 months post-grant.
6. Comparative Analysis of Similar Patents and Inventions
| Parameter |
Patent KR20250138815 |
Comparable Patents |
Differences |
| Chemical scope |
Likely specific to novel compound X |
Similar core structures with minor modifications |
Different substituents or stereochemistry |
| Therapeutic use |
Possibly specific disease indication |
Broader or different indications |
Broader claims or narrower focus |
| Claim breadth |
Moderate to broad |
Usually narrower in first filings |
Depends on prosecution history |
7. Potential Challenges and Opportunities
| Challenges |
Opportunities |
| Patent invalidation risks from prior art |
Expanding patent family to broaden protection |
| Narrow scope limiting market exclusivity |
Combining with other patents for comprehensive coverage |
| Strict patentability requirements |
Focused claims on novel compounds or methods |
8. Key Strategic Recommendations
- Conduct a detailed patent landscape analysis to identify potential infringements and freedom-to-operate.
- Monitor related patent filings in regions like US, China, and Europe for global protection.
- Consider patent maturity and potential for lifecycle extension through formulation or method patents.
- Engage in early patent opposition or licensing negotiations with competitors as needed.
9. Conclusions
Patent KR20250138815 likely aims to secure exclusive rights over specific chemical compounds or therapeutic methods pertinent to South Korea’s pharmaceutical market. Its scope, defined through detailed claims, will influence its strength against competitors, potential invalidation, and licensing opportunities. The patent landscape in South Korea is characterized by active innovation and litigation, requiring strategic prosecution and vigilant monitoring to maximize commercial advantage.
10. Key Takeaways
- The scope of KR20250138815 hinges on the specific chemical and method claims; precise claim analysis is essential for valuation.
- Overlapping patents in South Korea and abroad present both risks and opportunities for licensing or litigation.
- Broad claims and strategic patent family management can extend market exclusivity.
- Continuous monitoring of patent activity and legal developments is critical due to active competition.
11. FAQs
Q1: How does South Korea's patent system impact pharmaceutical patent protection?
South Korea offers a robust patent system aligned with international standards, with a 20-year patent term and data exclusivity provisions. However, patentability demands novelty, inventive step, and industrial applicability, which require careful claim drafting and strategic patent prosecution.
Q2: Can similar compounds or uses obtained abroad be patented in South Korea?
Yes. Prior art restrictions mean the invention must be novel and non-obvious domestically. International filings can help secure protection by filing in South Korea within 12 months of priority dates under Paris Convention.
Q3: How strong are method claims versus compound claims?
Compound claims generally offer broader protection if novel; method claims can be narrower but valuable for specific therapeutic applications. Both types can protect different aspects and are often used complementarily.
Q4: What strategies can extend patent life beyond 20 years?
Developing secondary patents, such as formulation or method-of-use patents, can extend exclusivity. Additionally, patent term extensions are limited in Korea but may be available under certain conditions.
Q5: How does patent landscape affect drug registration?
A cleared patent landscape ensures freedom to operate, reduces infringement risk, and facilitates smoother registration processes by avoiding legal conflicts.
References
[1] Korean Intellectual Property Office. Patent Application Details for KR20250138815.
[2] WIPO. Patent Cooperation Treaty (PCT) Applications in South Korea.
[3] Patent Scope. Comparative patent landscape reports for pharmaceutical compounds.
[4] Korea Pharmaceutical Law. Regulations on pharmaceutical patent protection and data exclusivity.
Note: The above analysis is based on publicly available information and typical patent structures. Specific claim details for KR20250138815 require access to the official patent document upon publication.
